Home/Cardiovascular Psychiatry and Neurology/Article Record
Peer-Reviewed Article June 20, 2010

The S100B/RAGE Axis in Alzheimer's Disease

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Cardiovascular Psychiatry and Neurology
Publisher: Hindawi Publishing Corporation • Egypt • 2090-0163
DOI: https://doi.org/10.1155/2010/539581

Abstract

Increasing evidence suggests that the small EF-hand calcium-binding protein S100B plays an important role in Alzheimer's disease. Among other evidences are the increased levels of both S100B and its receptor, the Receptor for Advanced Glycation Endproducts (RAGEs) in the AD diseased brain. The regulation of RAGE signaling by S100B is complex and probably involves other ligands including the amyloid beta peptide (Abeta), the Advanced Glycation Endproducts (AGEs), or transtheyretin. In this paper we discuss the current literature regarding the role of S100B/RAGE activation in Alzheimer's disease.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

93
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.